Relay Therapeutics, Inc. (RLAY)
14.08
+0.42
(+3.11%)
USD |
NASDAQ |
Jun 09, 16:00
13.81
-0.28
(-1.95%)
After-Hours: 20:00
Relay Therapeutics Profit Margin (Quarterly) : -2.44K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | -- |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| Exelixis, Inc. | 34.46% |
| Insmed, Inc. | -53.46% |
| United Therapeutics Corp. | 35.18% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.56% |
| Return on Assets | -38.75% |
| Return on Invested Capital | -40.31% |
| Gross Profit Margin (Quarterly) | 83.20% |
| Operating Margin (Quarterly) | -2.62K% |
| Return on Net Operating Assets | -425.5% |